Kinled Holding logo

Kinled Holding

North America, New York, United States, New York

Description

Kinled focuses on start-ups and growth companies with strong identifiable patented technology.

Investor Profile

Kinled Holding has made 109 investments, with 0 in the past 12 months and 4% as lead.

Stage Focus

  • Seed (47%)
  • Series A (22%)
  • Series Unknown (21%)
  • Series B (6%)
  • Series C (2%)
  • Series D (1%)
  • Series E (1%)

Country Focus

  • United Kingdom (28%)
  • United States (17%)
  • Switzerland (17%)
  • Germany (10%)
  • Austria (6%)
  • France (5%)
  • Spain (3%)
  • The Netherlands (2%)
  • Singapore (1%)
  • Canada (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Software
  • Financial Services
  • Fintech
  • Medical
  • Medical Device
  • Therapeutics
  • Information Technology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kinled Holding frequently co-invest with?

Speedinvest
Europe, Wien, Austria, Vienna
Co-Investments: 15
Seedcamp
Europe, England, United Kingdom, London
Co-Investments: 6
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
Concentric
Europe, England, United Kingdom, London
Co-Investments: 6
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 6
Pureos Bioventures
Europe, Zurich, Switzerland, Küsnacht
Co-Investments: 9
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 3
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 4

Which angels does Kinled Holding often collaborate with?

CG
North America, California, United States, San Francisco
Shared Deals: 1
MM
Europe, Bayern, Germany, Munich
Shared Deals: 1
BL
North America, California, United States, Stanford
Shared Deals: 1
AR
North America, California, United States, San Francisco
Shared Deals: 1
LS
North America, California, United States, Palo Alto
Shared Deals: 1
JW
North America, California, United States, San Francisco
Shared Deals: 1
OP
North America, New York, United States, New York
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
MP
North America, California, United States, San Francisco
Shared Deals: 1
MH
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Kinled Holding?

Xapien

London, England, United Kingdom

Xapien automates online research, using Artificial Intelligence, Natural Language Processing & with vast cloud compute power: #XapienThem

Financial ServicesFinTechInformation TechnologyLegal TechNatural Language ProcessingSaaSSearch EngineSoftware
SeedApr 12, 2023
Amount Raised: $7,495,194
Connect Earth

London, England, United Kingdom

Connecting carbon data to drive sustainable finance

Environmental ConsultingFinTech
SeedMar 28, 2023
Amount Raised: $5,548,363
OneTrust

Atlanta, Georgia, United States

OneTrust provides a platform that helps companies manage privacy, security, compliance, and governance requirements.

ComplianceCyber SecurityData GovernanceInformation TechnologyRisk ManagementSoftware
Series UnknownMar 3, 2023
Amount Raised: $50,000,000
Nanoflex Robotics

Zürich, Zurich, Switzerland

Nanoflex Robotics provides advancing medical robotic interventions for the treatment of ischemic stroke.

Health CareMedical DeviceRobotics
Series AFeb 10, 2023
Amount Raised: $12,000,000
hi.health

Vienna, Wien, Austria

We are reinventing the claims process in private health insurance combining payment cards with a pay&claim solution

FinTechHealth CareHealth InsuranceInformation TechnologyInsurTechPayments
SeedJan 11, 2023
Amount Raised: $6,459,371
CEBINA Bridge Capital

Gibraltar, Gibraltar, Gibraltar

CEBINA Bridge Capital invests in pharmaceutical drug discovery and biotech projects in Central and Eastern Europe.

Biotechnology
SeedJan 1, 2023
Algonist Biotechnologies

Vienna, Wien, Austria

Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain.

BiotechnologyPharmaceutical
Series UnknownJan 1, 2023
Five Lives

London, England, United Kingdom

Five Lives specializes in building the most accessible, affordable and clinically-validated brain health platform.

Health CareMedical Device
SeedNov 15, 2022
Amount Raised: $3,832,275
Ahead App

Berlin, Berlin, Germany

Ahead is a personalized pocket coach that provides bite-sized, science-driven tools to boost emotional intelligence.

E-Learning
SeedNov 4, 2022
PreComb Therapeutics

Hombrechtikon, Zurich, Switzerland

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.

BiotechnologyHealth CareLife ScienceTherapeutics
SeedOct 4, 2022
Amount Raised: $1,328,184